| Obtaining US MSB License, Anmrex Exchange Accelerates Global Compliance Deployment |
Globe Newswire |
04/28 |
03:02 |
| The Brand DEM Surpasses Major Revenue Milestone as 17-Year-Old Founder DeMarco Expands Direct-to-Consumer Growth Strategy |
Globe Newswire |
04/28 |
03:01 |
| Increasing California’s Postsecondary Attainment Rate to 70% for All Demographic Groups by 2035 Would Generate $4.4 Trillion in Net Monetary Gains for the State and Its Residents, Georgetown University Report Says |
Globe Newswire |
04/28 |
03:01 |
| Precore Gold Welcomes Tenured Geologist Raúl Carbajal as Senior Project Manager at Its Arikepay Project in Peru |
Globe Newswire |
04/28 |
03:00 |
| Raiffeisenbankengruppe Oesterreich (excluding Raiffeisen Bank International) Selects nCino to Modernise Corporate Lending Across Its Nationwide Network |
Globe Newswire |
04/28 |
02:30 |
| Quadient and Solix Strengthen SaaS Communications Lifecycle with Expansion of Advanced Enterprise Archiving |
Globe Newswire |
04/28 |
02:30 |
| TEELX Announces Strategic Partnership to Advance AI-Driven Quantitative Trading |
Globe Newswire |
04/28 |
02:25 |
| Zealand Pharma announces Boehringer Ingelheim's novel glucagon/GLP-1 dual agonist survodutide achieved significant weight loss of 16.6% delivering meaningful metabolic improvement in people with obesity or overweight in Phase 3 trial |
Globe Newswire |
04/28 |
02:00 |
| Progress on share buyback programme |
Globe Newswire |
04/28 |
02:00 |
| STMicroelectronics brings always-on vision to next-generation personal electronics with new ultralow-power image sensors |
Globe Newswire |
04/28 |
02:00 |
| Boehringer Ingelheim’s novel glucagon/GLP-1 dual agonist survodutide achieved significant weight loss of 16.6% delivering meaningful metabolic improvement in people with obesity or overweight in Phase III trial |
Globe Newswire |
04/28 |
02:00 |
| Santhera Announces Positive AIFA Board Decision on Reimbursement of AGAMREE® (vamorolone) in Italy |
Globe Newswire |
04/28 |
01:01 |
| Nexans - Q1 2026, Solid start to 2026 |
Globe Newswire |
04/28 |
01:00 |
| Santhera Pharmaceuticals Full Year Results for the Year Ended 31 December 2025 |
Globe Newswire |
04/28 |
01:00 |
| CORE Soft Tissue Therapy Reports Full Booking Capacity in First Year as Referral Growth Supports South London Expansion |
Globe Newswire |
04/28 |
00:15 |
| ZenithBlox and My Blockchain Infrastructure Sdn. Bhd. Complete Technical Integration to Enable Programmable Cross-Border Trade |
Globe Newswire |
04/27 |
22:37 |
| The World’s First Parking Hack for Young People! OMODA&JAECOO VPD Technology Makes Its Global Debut |
Globe Newswire |
04/27 |
22:17 |
| OMODA & JAECOO Brings AiMOGA Robotics Make Joint Debut at Beijing Autoshow: From Mobility Ecosystem to Embodied Intelligence |
Globe Newswire |
04/27 |
22:15 |
| REGENCELL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Regencell Bioscience Holdings Limited and Encourages Investors to Contact the Firm |
Globe Newswire |
04/27 |
21:35 |
| ROSEN, LEADING INVESTOR COUNSEL, Encourages SES AI Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – SES |
Globe Newswire |
04/27 |
21:30 |
| ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Globant S.A. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GLOB |
Globe Newswire |
04/27 |
21:04 |
| Arch Capital Management Launches to Provide Flexible Working Capital, Factoring, and ABL Facilities |
Globe Newswire |
04/27 |
20:49 |
| VERI SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations |
Globe Newswire |
04/27 |
20:26 |
| NNOX SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations |
Globe Newswire |
04/27 |
20:22 |
| Smart Sellers Academy Introduces Industry‑Wide Standard for Trust and Transparency in E‑Commerce |
Globe Newswire |
04/27 |
20:14 |
